ULTRASE MT 18
Generic Name: pancrelipase
Pill imprint ULTRASE MT 18 has been identified as Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease.
Ultrase MT 18 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease is not subject to the Controlled Substances Act.
See also related documents.
Ultrase MT 18 Images
- Generic Name:
- pancrelipase
- Imprint:
-
ULTRASE
MT 18 - Strength:
- 58,500 units amylase; 18,000 units lipase; 58,500 units protease
- Color:
- Gray / White
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Axcan Scandipharm Inc.
- National Drug Code (NDC):
- 58914-0018
More Ultrase MT 18 resources
- Ultrase MT 18 (Cerner Multum)


